Data / Form D filings / Commense Bio, Inc.
Commense Bio, Inc.: Form D filing
Commense Bio, Inc., a biotechnology company in Boulder, CO, filed a Form D with the SEC in 2026. The latest, on June 12, 2026, reports $2.5 million sold of a $2.7 million offering to 31 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2805 WILDERNESS PLACE, SUITE 1000, Boulder, CO, 80301
- Phone
- (720) 755-5807
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2135129
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | New notice | $2,671,875 | $2,470,334 | $201,541 | 31 | Jan 18, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Erik Prentice | Director | |
| N. Stuart Harris | Director | |
| Joshua Smith | Director | |
| Judith Boice | Director | |
| Todd Turner | Executive Officer, Director | |
| Randall W. Viola | Director |
Other biotechnology companies in Colorado that filed recently
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
- Shiverbright Technologies, Inc. $200,000 · Aug 7, 2026
Every Form D from the week of Jun 8, 2026 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Commense Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.